Biomed Central Ltd

SHERPA: Unknown

People

  1. Faleck
    Faleck
  2. Laszkowska
    Laszkowska
  3. Maron
    Maron
  4. Postow
    Postow
  5. Janjigian
    Janjigian
  6. Mendelsohn
    Mendelsohn
  7. Schattner
    Schattner
  8. Srivastava
    Srivastava

Groups

  1. Department of Medicine (6)
  2. Division of Subspecialty Medicine (6)
  3. Gastroenterology, Hepatology and Nutrition (6)
  4. Solid Tumor Oncology Division (5)
  5. Melanoma and Immunotherapeutics Service (3)
  6. GME, Medicine (2)
  7. Gastrointestinal Oncology Service (2)
  8. Graduate Medical Education (2)
  9. Melanoma Disease Management Team (2)
  10. Population Sciences Research Program (2)
Search Within
  1. "David Faleck"
Formats
  1. Journal Article (4)
  2. Correspondence (1)
  3. Meeting Abstract (1)
Groups
  1. Department of Medicine (6)
  2. Division of Subspecialty Medicine (6)
  3. Gastroenterology, Hepatology and Nutrition (6)
  4. Solid Tumor Oncology Division (5)
  5. Melanoma and Immunotherapeutics Service (3)
  6. GME, Medicine (2)

More Groups

People
  1. David Faleck (6)
  2. Michael Postow (2)
  3. Monika Laszkowska (2)
  4. Steven Maron (2)
  5. Amitabh Srivastava (1)
  6. Darren Cowzer (1)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2021 (1)
  4. 2019 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Corso, T.; Livingstone, P.; Tom, E.; Srivastava, A.; Postow, M.; Faleck, D.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Response to Yu and Fuhler et al
    Correspondence

    Magahis, P. T.; Maron, S. B.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Maron, S. B.; Cowzer, D.; King, S.; Schattner, M.; Janjigian, Y.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Journal Article

    Badran, Y. R.; Zou, F.; Durbin, S. M.; Dutra, B. E.; Abu-Sbeih, H.; Thomas, A. S.; Altan, M.; Thompson, J. A.; Qiao, W.; Leet, D. E.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: A two-center observational study
    Journal Article

    Zou, F.; Faleck, D.; Thomas, A.; Harris, J.; Satish, D.; Wang, X.; Charabaty, A.; Ernstoff, M. S.; Glitza Oliva, I. C.; Hanauer, S.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
    Meeting Abstract

    Abu-Sbeih, H.; Faleck, D.; Ricciuti, B.; Mendelsohn, R.; Naqash, A. R.; Cohen, J.; Sellars, M.; Balaji, A.; Ben-Betzalel, G.; Hajir, I.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save